| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Diekman John D serves as a Director at ZLAB and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 4 sells.
Historically, Diekman John D's trades have earned a strong insider score of 77/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +57.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2022 | ZLAB Zai Lab Ltd | Director | Sell | 1,000 | $50.17 | $50,170.00 | -1.5% | -28.2% | -19.5% | |
| Nov 5, 2021 | ZLAB Zai Lab Ltd | Director | Sell | 1,000 | $91.65 | $91,650.00 | -1.6% | -42.7% | -65.0% | |
| Aug 5, 2021 | ZLAB Zai Lab Ltd | Director | Sell | 1,000 | $149.50 | $149,500.00 | -1.6% | -30.7% | -69.8% | |
| May 5, 2021 | ZLAB Zai Lab Ltd | Director | Sell | 1,000 | $153.62 | $153,620.00 | -1.6% | -2.6% | -76.4% | |
| May 28, 2019 | IDYA Ideaya Biosciences, Inc. | Director | Buy | 250,000 | $10.00 | $2,500,000.00 | -190.1% | - | - |